|
|
Article: PharmaStem Therapeutics Initiates New Lawsuits to Protect Its Umbilical Cord Blood Stem Cell Patent Rights; Lawsuits Have Been Filed Against ViaCell, Cryo-Cell International, Cord Blood Registry -CBR Systems-, Corcell and Certain Obstetricians.
- Article from:
- Business Wire
- Article date:
- August 2, 2004
CopyrightCOPYRIGHT 2004 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
WAYNE, Pa. -- PharmaStem Therapeutics, Inc. announced today that it has initiated multiple lawsuits for patent infringement to protect its intellectual property rights relating to umbilical cord blood stem cells. PharmaStem is the successor to Biocyte Corporation, the pioneer in the discovery and development of umbilical cord blood preservation and its therapeutic use. In recognition of its leadership, PharmaStem has received five U.S. Patents to date for its technological advances.
The new lawsuits assert infringement of two recently issued patents, U.S. Patent Nos. 6,569,427 and/or 6,605,275, which relate to the cryopreservation and therapeutic use of umbilical ...